Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edgar L. Thomas is active.

Publication


Featured researches published by Edgar L. Thomas.


American Journal of Ophthalmology | 2010

The Association of Smoking and Alcohol Use with Age-Related Macular Degeneration in the Oldest Old: the Study of Osteoporotic Fractures

Anne L. Coleman; Robin L. Seitzman; Steven R. Cummings; Fei Yu; Jane A. Cauley; Kristine E. Ensrud; Katie L. Stone; Marc C. Hochberg; Kathryn L. Pedula; Edgar L. Thomas; Carol M. Mangione

PURPOSE To estimate the incidence of age-related macular degeneration (AMD) and the association of smoking and alcohol in a population of older women. DESIGN Prospective cohort study. METHODS Subjects were women who attended the Study of Osteoporotic Fractures year-10 and year-15 follow-up clinic visits and had fundus photographs taken at both visits (n = 1958; 245 Black and 1713 White subjects; mean age at year 10 visit, 78.2 years). Forty-five degree stereoscopic fundus photographs were graded for AMD. Logistic regression was used to test whether risk factors were associated with incident AMD. RESULTS The overall 5-year AMD incidence was 24.1% (95% confidence interval [CI], 21.7 to 26.6) for early and 5.7% (95% CI, 4.6 to 6.8) for late. Early AMD incidence in White subjects ranged from 21.9% in those aged 74 to 79 years to 33.2% in those 80 to 84 years, but was observed at the slightly lower rate of 29.0% in subjects > or =85 years (trend P < .0001). After confounder adjustment, alcohol consumption was significantly associated with an elevated risk of incident early AMD (odds ratio [OR], 1.57; 95% CI, 1.18 to 2.11). There was an increased risk of early AMD among subjects aged 80 years or older who were smoking compared to those younger than 80 years who were not smoking (OR, 5.49; 95% CI, 1.57 to 19.20; P for interaction = .026). CONCLUSIONS The magnitude of the greater-than-additive effect of smoking on the age-adjusted risk of AMD reinforces recommendations to quit smoking even for older individuals.


American Journal of Ophthalmology | 1979

Prevention and Treatment of Symblepharon

Herbert E. Kaufman; Edgar L. Thomas

Symblepharon after acute conjunctival injury can be prevented by separating the raw surfaces for one to two weeks, until re-epithelialization takes place. We have used a soft contact lens and a conjunctival ring without a corneal center, or lined the eyelid and palpebral conjunctiva with plastic. This often eliminates the need for mucous membrane grafts. Symblepharon can interfere with intraocular surgery and disrupt cataract incisions unless they are divided and separated at the time of surgery.


Current Eye Research | 2004

Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathy

Mehryar Taban; Edgar L. Thomas; David S. Boyer; Roger Novack; Thomas G. Chu; Ron P. Gallemore

Purpose. To demonstrate the efficacy of photodynamic therapy (PDT) in treating choroidal neovascularization (CNV) induced by laser photocoagulation for diabetic macular edema and its ancillary effect on surrounding diabetic microvascular abnormalities. Methods. A retrospective interventional case series study in a clinical practice setting of four patients with proliferative diabetic retinopathy and clinically significant macular edema who had developed classic CNV in proximity to the area of previous laser photocoagulation. The lesions were treated with verteporfin PDT and followed with serial fluorescein angiography. Results. Compared to the pre-treatment angiogram, an acute reduction in leakage from CNV was noted as soon as 5 days post-PDT and persisted in some areas up to three months post-treatment within the zone of the typical dark choroid pattern. No evidence of any closure of microaneurysms was noted. Conclusions. Serial fluorescein angiograms demonstrate that PDT appears to have a beneficial effect on CNV induced by laser photocoagulation for diabetic macular edema without any tangible beneficial effect on diabetic microvasculopathy. PDT had no effect on existing microaneurysms.


American Journal of Ophthalmology | 2005

Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage

Baruch D. Kuppermann; Edgar L. Thomas; Marc D. de Smet; Lisa R. Grillone


American Journal of Ophthalmology | 2005

Safety Results of Two Phase III Trials of an Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase®) for the Management of Vitreous Hemorrhage

Baruch D. Kuppermann; Edgar L. Thomas; Marc D. de Smet; Lisa R. Grillone


Archive | 2005

VITRASE FOR VITREOUS HEMORRHAGE STUDY GROUPS. POOLED EFFICACY RESULTS FROM TWO MULTINATIONAL RANDOMIZED CONTROLLED CLINICAL TRIALS OF A SINGLE INTRAVITREOUS INJECTION OF HIGHLY PURIFIED BOVINE HYALURONIDASE (VITRASE) FOR THE MANAGEMENT OF VITREOUS HEMORRHAGE

Baruch D. Kuppermann; Edgar L. Thomas; De Smet; Lisa R. Grillone


American Journal of Ophthalmology | 2002

Management of pupillary block glaucoma in phakic patients after vitrectomy with silicone oil injection.

Felipe Navas; David S. Boyer; Edgar L. Thomas; Roger L Novak; Thomas G. Chu; Ron P. Gallemore


American Journal of Ophthalmology | 2005

Long-Term Safety and Efficacy of Repositioning Dislocated Plate Haptic Intraocular Lenses in the Ciliary Sulcus

N.J. Rudometkin; Edgar L. Thomas; Richmond E. Roeske; Robert N. Fabricant


/data/revues/00029394/v137i6/S000293940400087X/ | 2011

Chronic central serous chorioretinopathy: photodynamic therapy

Mehryar Taban; David S. Boyer; Edgar L. Thomas; Mehran Taban


Archive | 2005

VITRASE FOR VITREOUS HEMORRHAGE STUDY GROUPS. SAFETY RESULTS OF TWO PHASE III TRIALS OF AN INTRAVITREOUS INJECTION OF HIGHLYPURIFIED BOVINE HYALURONIDASE (VITRASE) FOR THE MANAGEMENT OF VITREOUS HEMORRHAGE

Baruch D. Kuppermann; Edgar L. Thomas; De Smet; Lisa R. Grillone

Collaboration


Dive into the Edgar L. Thomas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David S. Boyer

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas G. Chu

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fei Yu

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jane A. Cauley

University of Pittsburgh

View shared research outputs
Researchain Logo
Decentralizing Knowledge